Eidos Therapeutics, a subsidiary of BridgeBio Pharma, is developing AG10 as a targeted therapeutic for transthyretin amyloidosis. The company’s singular mission is to improve and prolong the lives of patients suffering from this disease.

Launched in 2016 after years of research supported by Stanford’s SPARK program, Eidos is led by a team of veteran biotechnology executives. Together with patients and physicians, the company aims to bring a safe, effective treatment to market as quickly as possible.

Biotechnology

Eidos Therapeutics

Eidos Therapeutics' headquarters in San Francisco, CA, United States

Neil Kumar

Anne Moriarty

Matt Outten

Uma Sinha

Mamoun Alhamadsheh

Isabella Graef

The Clinical Research and Development team at Eidos Therapeutics is dedicated to designing, implementing, and overseeing clinical trials aimed at evaluating the safety and efficacy of AG10 for transthyretin amyloidosis. This team, composed of experienced professionals in clinical operations and regulatory affairs, collaborates closely to ensure trials meet regulatory standards and are conducted efficiently, ultimately working to bring innovative therapies to patients in need.

Clinical Research and Development

The Leadership Team at Eidos Therapeutics is responsible for guiding the strategic direction and operational execution of the company. Comprising seasoned biotechnology executives and co-founders, this team collaborates to drive the development of AG10, ensuring alignment with the company’s mission to improve the lives of patients with transthyretin amyloidosis. They focus on making critical decisions regarding research priorities, commercial strategy, and partnership opportunities to expedite the delivery of safe and effective therapies to market.

Leadership Team

This department manages the planning, execution, and oversight of clinical trials to ensure compliance and data integrity.

Clinical Operations

This department focuses on managing employee relations, recruitment, and organizational development.

Human Resources

This department oversees the progression of drug substances and drug products from initial development through to production.

Pharmaceutical Development

This department ensures the consistency and reliability of products through rigorous testing and analysis.

Eidos Therapeutics

Org chart

Board & advisors

Teams

Clinical Research and Development

Leadership Team

Clinical Operations

Human Resources

Pharmaceutical Development

Quality Assurance

Offices

Eidos Therapeutics

Org chart

Board & advisors

Teams

Clinical Research and Development

Leadership Team

Clinical Operations

Human Resources

Pharmaceutical Development

Quality Assurance

Offices

Related companies